FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Akorn COSOPT Ophthalmic Solution Recall

COSOPT Ophthalmic Solution, USP, (2% Dorzolamide Hydrochloride, 0

Akorn Inc · Lake Forest, IL

Risk level
Class III
Reported by FDA
Feb 20, 2019
Recall ID
D-0483-2019
Check your lot numberHow we source this data

Summary

Akorn recalled COSOPT Ophthalmic Solution starting Dec 20, 2018. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0483-2019 on Feb 20, 2019. Reason: Failed Stability Specifications: out of specification results for opalescence at 7 month stability study. Status: Terminated.

Why it was recalled

Failed Stability Specifications: out of specification results for opalescence at 7 month stability study.

Product description

COSOPT Ophthalmic Solution, USP, (2% Dorzolamide Hydrochloride, 0.5% Timolol Maleate), 10 mL dropper bottle, Sterile, Rx only, Distributed by: Akorn, Inc., Lake Forest, IL, NDC: 17478-605-10

Lot numbers, UPCs & expiration codes

Lots: 426007 and 426008, exp 4/2020

Where it was sold

Nationwide USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0483-2019
Classification
Class III
Status
Terminated
Recall initiated
Dec 20, 2018
FDA report date
Feb 20, 2019
Quantity
30,794 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Akorn Inc

Original FDA data

Every field from FDA enforcement report D-0483-2019, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
81836
Address
1925 W Field Ct Ste 300
Code information
Lots: 426007 and 426008, exp 4/2020
Postal code
60045-4862
Report date
Feb 20, 2019
Product type
Drugs
Recall number
D-0483-2019
Classification
Class III
Recalling firm
Akorn Inc
Product quantity
30,794 bottles
Termination date
Nov 6, 2020
Reason for recall
Failed Stability Specifications: out of specification results for opalescence at 7 month stability study.
Voluntary / mandated
Voluntary: Firm initiated
Product description
COSOPT Ophthalmic Solution, USP, (2% Dorzolamide Hydrochloride, 0.5% Timolol Maleate), 10 mL dropper bottle, Sterile, Rx only, Distributed by: Akorn, Inc., Lake Forest, IL, NDC: 17478-605-10
Distribution pattern
Nationwide USA and Puerto Rico
Recall initiation date
Dec 20, 2018
Initial firm notification
Letter
Center classification date
Feb 8, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0483-2019, published Feb 20, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls